Search research articles
Contact Us
Filters
Showing results (41-50 of 118) with videos related to
Page
of 12
Sort By:
International Journal of Oncology
|
April 10, 2003
Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?
Leonardo Ferrari, Emilio Bajetta, Antonia Martinetti, et al.
Cancer Immunology, Immunotherapy : CII
|
February 10, 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang, Luca Gattinoni, Gattinoni Luca, et al.
Genome Research
|
July 29, 2011
Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1
Gangqing Hu, Dustin E Schones, Kairong Cui, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
Claudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2005
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women
Emilio Bajetta, Giuseppe Procopio, Luigi Celio, et al.
JCI Insight
|
March 15, 2017
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
Jacob S Bowers, Michelle H Nelson, Kinga Majchrzak, et al.
Cancer Research
|
March 17, 2007
Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling
Yangbing Zhao, Maria R Parkhurst, Zhili Zheng, et al.
Blood
|
August 3, 2006
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent
Luca Gattinoni, Anju Ranganathan, Deborah R Surman, et al.
The Journal of Clinical Investigation
|
June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
Luca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Plos One
|
May 16, 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing
Yun Ji, Natalie Abrams, Wei Zhu, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 118) with videos related to
Sort By:
Page
of 12
International Journal of Oncology
|
April 10, 2003
Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?
Leonardo Ferrari, Emilio Bajetta, Antonia Martinetti, et al.
Cancer Immunology, Immunotherapy : CII
|
February 10, 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang, Luca Gattinoni, Gattinoni Luca, et al.
Genome Research
|
July 29, 2011
Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1
Gangqing Hu, Dustin E Schones, Kairong Cui, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
Claudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2005
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women
Emilio Bajetta, Giuseppe Procopio, Luigi Celio, et al.
JCI Insight
|
March 15, 2017
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
Jacob S Bowers, Michelle H Nelson, Kinga Majchrzak, et al.
Cancer Research
|
March 17, 2007
Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling
Yangbing Zhao, Maria R Parkhurst, Zhili Zheng, et al.
Blood
|
August 3, 2006
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent
Luca Gattinoni, Anju Ranganathan, Deborah R Surman, et al.
The Journal of Clinical Investigation
|
June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
Luca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Plos One
|
May 16, 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing
Yun Ji, Natalie Abrams, Wei Zhu, et al.
Page
of 12